Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD

Launched by BOEHRINGER INGELHEIM · Feb 12, 2016

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Male or female patients.
• • Patients 40 years of age or older.
• • Patients with a smoking history \> 10 pack years.
• • Diagnostic of COPD with Post-bronchodilator FEV1 (Forced Expiratory Volume in one second) \>= 30% and \<80% of predicted normal and Post-bronchodilator FEV1/FVC (Forced Vital Capacity) \<70% at screening.
• • Symptomatic patients with CAT (COPD Assessment Test TM) score \>= 10 at screening.
• • Further inclusion criteria apply.
• Exclusion criteria:
• • COPD exacerbation or symptoms of lower respiratory tract infection within 6 weeks prior to screening.
• • Patients with a current diagnosis of asthma.
• • Further exclusion criteria apply.